Tag: Princeton University’s Office of Communications
-
Former Merck official talks about potential COVID-19 vaccines
The former president of the Merck Vaccine Division of Merck & Co. believes that despite ramped-up efforts to develop a vaccine against COVID-19, scientists are more likely to develop anti-viral treatments first. Gordon Douglas, M.D., spoke about COVID-19 and what it takes to develop a vaccine in the May 18 episode of Princeton University’s podcast,…